Clinical Outcome of Post placental PPIUCD in a Primigravida Women Delivering by Caesarean Section

Abstract

Objective- To assess the safety and efficacy of post-partum IUCD during ceasarean section in a primigravida women. Method: This prospective observational study includes 100 women, who gave informed consent for post-partum intrauterine device insertion during cesarean section from Oct 2018 to Oct 2019 in the department of Obstetrics and Gynaecology, GMC Shivpuri associated District hospital Shivpuri Madhya Pradesh. The patients were followed up at 4-6 wk and at 3 months. Result: A total of 100 primigravida women underwent postpartum intracesarean insertion of CuT-375. The most common post insertion complication observed in the immediate post-operative period was wound infection (8%) and febrile morbidity (5%) majority of women (88%)had hospital stay b/w 5-8 days .The common adverse events observed during follow up at 3 month were pelvic pain, menstrual irregularity and other genralized complaints. At the end of 3 months cumulative expulsion, removal, pregnancy/ failure, and continuation rates are 2%, 6%, 0% and 92% respectively. Conclusion- Post placental intracesarean CuT- 375 insertion in primigravida women is a safe and effective method of reversible contraceptive with low expulsion and high continuation rate.